These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3591124)

  • 21. [A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children].
    Burtseva EI; Obrosova-Serova NP; Govorkova EA; Rudenko LG; Vartanian RV; Beliaev AL; Ivanova VT; Musina MD; Cheshek SG; Zazimko LA
    Vopr Virusol; 1991; 36(5):375-7. PubMed ID: 1803767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.
    Khan AS; Polezhaev F; Vasiljeva R; Drinevsky V; Buffington J; Gary H; Sominina A; Keitel W; Regnery H; Lonskaya NL; Doroshenko E; Gavrilov A; Ivakhov I; Arden N; Schonberger LB; Couch R; Kendal A; Cox N
    J Infect Dis; 1996 Feb; 173(2):453-6. PubMed ID: 8568310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
    Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14].
    Rudenko LG; Ramirez A; Barro M; Gushchina MI; Armanda RE; Ermachenko TA; Romanova IuR; Grigor'eva EP; Aleksandrova GI; Lonskaia NI
    Vopr Virusol; 1991; 36(6):472-4. PubMed ID: 1785181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Live influenza vaccine in the USSR: its development, study and practical use].
    Zhdanov VM; Aleksandrova GI; Gendon IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):3-13. PubMed ID: 3529762
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines].
    Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS
    Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Basic results of a committee trial of the new vaccine Grippovac SE-AZh].
    Bashliaeva ZA; Sumarokov AA; Nefedova LA; Iaroshevskaia IIu; Ozeretskovskaia NA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Feb; (2):49-54. PubMed ID: 3515812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.
    Coelingh K; Olajide IR; MacDonald P; Yogev R
    Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety.
    Wright PF; Cherry JD; Foy HM; Glezen WP; Hall CB; McIntosh K; Monto AS; Parrott RH; Portnoy B; Taber LH
    Rev Infect Dis; 1983; 5(4):758-64. PubMed ID: 6353530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old].
    Grigor'eva EP; Rekstin AR; Rudenko LG; Ramirez A; Barro M; Lisovskaia KV; Klimov AI; Aleksandrova GI
    Vopr Virusol; 1994; 39(1):26-9. PubMed ID: 8160445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
    Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
    Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The evaluation of the reactogenicity, harmlessness and prophylactic efficacy of Grippol trivalent polymer-subunit influenza vaccine administered to schoolchildren].
    El'shina GA; Gorbunov MA; Bektimirov TA; Lonskaia NI; Pavlova LI; Nikul'shin AA; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):50-4. PubMed ID: 10808574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiological investigations in young children's communities concerning the efficiency of prophylactic immunization with inactivated influenza vaccine (I.C. 80) in a preepidemic season.
    Măgureanu E; Busuioc C; Ionescu V; Tisu A; Coban V; Stoicescu A; Guguianu E; Calomfirescu N; Bordeianu V; Toma C
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):233-8. PubMed ID: 7159214
    [No Abstract]   [Full Text] [Related]  

  • 34. [Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine].
    Rudenko LG; Vasil'eva RI; Smirnova LA; Doroshenko EM
    Vopr Virusol; 1988; 33(4):407-11. PubMed ID: 3195142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.
    Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN
    J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
    Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
    Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.
    Treanor JJ; Betts RF
    Vaccine; 1998 Nov; 16(18):1756-60. PubMed ID: 9778752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The system of population protection against influenza.
    Shadrin AS; Karpukhin GI; Gararinova VM; Ivanova AS; Erophejeva MK; Efremov BV; Ignatjeva GS; Kustikova YuG ; Maksakova VL; Turjeva AV
    Z Erkr Atmungsorgane; 1985; 165(2):163-70. PubMed ID: 4082659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
    Lina B; Fletcher MA; Valette M; Saliou P; Aymard M
    Biologicals; 2000 Jun; 28(2):95-103. PubMed ID: 10885616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The evaluation of the epidemiological efficacy of 3-component inactivated influenza vaccines using an intranasal application method].
    Marinich IG; Iaroshevskaia IIu; Konareva AL; Lonskaia NI; Shadrin AS; Salmin LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):76-8. PubMed ID: 8079581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.